Real‐world data of poly (ADP‐ribose) polymerase inhibitor response in Japanese patients with ovarian cancer

Abstract Background Poly (ADP‐ribose) polymerase (PARP) inhibitors have been increasingly used in the treatment of ovarian cancer, with BRCA positivity and homologous recombination deficiency (HRD) being common biomarkers used for predicting their efficacy. However, given the limitations of these bi...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ryosuke Uekusa, Akira Yokoi, Eri Watanabe, Kosuke Yoshida, Masato Yoshihara, Satoshi Tamauchi, Yusuke Shimizu, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2024-04-01
Serie:	Cancer Medicine
Soggetti:	niraparib olaparib ovarian cancer PARP inhibitors real‐world data
Accesso online:	https://doi.org/10.1002/cam4.7149
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!